The company has produced a wearable head sensor and software that allows therapists to prescribe and track exercises carried out by patients, monitor patient symptoms and therefore gain insights into the effectiveness of treatments.The funding will lead to the creation of 10 new jobs and will help the team to continue product development and expand into the UK and US markets.
"Worldwide, patients who have been diagnosed with vertigo can face months-long waiting lists or an inability to get access to treatment at all," said Mark Barry, CEO, Vertigenius. Atlantic Bridge led the funding round, which also included investments from Ascentifi and Enterprise Ireland.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: